Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Insomnia App Recommended by NICE Unavailable Across Most of NHS

A digital app for insomnia, endorsed by NICE, is largely inaccessible through the NHS, according to a recent report. This limits patient access to a clinically recommended treatment for chronic sleep difficulties.

  • Sleepio, an app for chronic insomnia, has been recommended by NICE since 2022.
  • A report by Future Care Capital reveals it is unavailable in most NHS regions.
  • This restricts patient access to a non-pharmacological, digital cognitive behavioural therapy.
  • Chronic insomnia affects up to 10% of the UK adult population.
  • Digital health tools are seen as crucial for addressing NHS waiting lists and improving access.

Millions of people with chronic insomnia are being denied access to a clinically proven digital treatment, despite it receiving official backing from health watchdogs two years ago. The sleep therapy app Sleepio, recommended by NICE in 2022, remains unavailable across most NHS areas—leaving patients struggling with a condition that affects up to one in ten adults.

Sleepio delivers digital cognitive behavioural therapy for insomnia (CBT-I), which NICE found to be both effective and cost-effective for treating chronic insomnia. The treatment could reduce reliance on sleeping pills whilst improving patient outcomes. Chronic insomnia—defined as difficulty falling or staying asleep for at least three nights weekly over three months—affects between 3% and 10% of UK adults. Left untreated, it significantly increases the risk of mental health problems, heart disease, and impaired daily functioning.

A new report from Future Care Capital reveals that despite positive NICE guidance, access to Sleepio remains patchy across England's Integrated Care Boards (ICBs). This postcode lottery means patients in certain areas cannot access this recommended non-drug treatment option, potentially worsening existing health inequalities. The finding is particularly concerning given the NHS's push towards digital health technologies to ease service pressures and improve care access.

The impact on patients is substantial. Those with chronic insomnia who could benefit from CBT-I may face lengthy waits for face-to-face therapy or receive less suitable treatments, such as sleeping tablets. These medications often cause side effects and aren't recommended for long-term use. For the NHS, failing to roll out this effective digital intervention more widely represents a missed opportunity to manage a common condition efficiently, potentially freeing up valuable resources in mental health and primary care.

NICE guidelines clearly state that CBT-I should be the first-line treatment for chronic insomnia, ahead of medication. The current situation highlights implementation challenges, particularly around digital therapeutics. Bridging this gap will require coordinated efforts between NHS commissioning bodies, digital health providers, and policymakers to ensure recommended digital tools are properly integrated into patient care pathways nationwide.

If you're experiencing persistent sleep difficulties, speak to your GP. They can assess your condition, discuss treatment options, and provide appropriate referrals. For urgent health concerns, call NHS 111.

Source: Future Care Capital

Why this matters: This matters to UK readers because it highlights a significant barrier to accessing a clinically recommended digital health treatment for a common condition, chronic insomnia. It also raises questions about the NHS's ability to integrate modern digital solutions effectively.

What this means for you: Patients struggling with chronic insomnia may face longer waits for NHS sleep clinic appointments or need to pay privately for the NICE-recommended app. Your GP may be unable to prescribe this digital treatment, potentially leaving you with limited options beyond traditional sleeping pills or lengthy referral processes for specialist sleep services.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.